Palomar Medical Technologies to Host Fourth Quarter and Year End 2010 Financial Results Conference Call and Webcast on February 10, 2011
BURLINGTON, Mass., Jan. 27, 2011 /PRNewswire/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, will hold its quarterly conference call of its 2010 fourth quarter and year-end financial results on Thursday, February 10, 2011 at 11:30 AM Eastern Time. If you would like to participate, please call (877) 415-3181 at 11:20 AM Eastern Time on that day.
A live webcast of Palomar's conference call will be available in the Investor Relations' section of the Company's web site www.palomarmedical.com. The online archive will be available one hour after the call and continue through Thursday, February 17, 2011.
For more information on Palomar and its products, visit Palomar's website at www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.
About Palomar Medical Technologies Inc: Palomar designs, produces and sells the most advanced cosmetic lasers and intense pulsed light (IPL) systems to dramatically improve the appearance of women's and men's skin. For over 15 years, Palomar has pioneered the science of using lasers and light to improve appearances. As the industry's technology leader, Palomar has invested in creating cosmetic laser and IPL systems that put real value in the hands of physicians and other professionals to benefit consumers. Thousands of physicians worldwide trust and depend on Palomar technology to not only introduce new aesthetic treatments such as advanced laser hair removal, laser liposuction, skin resurfacing, acne, laser treatments for scars, wrinkle treatment, stretch marks (striae), and photofacials for pigmented and vascular lesions, but to also make them robust, faster, more powerful, and more comfortable for those being treated. In June 2009, Palomar became the first company to receive a 510(k) over-the-counter ("OTC") clearance from the FDA for a new, patented, home-use, laser device for the treatment of fine lines and wrinkles around the eyes (periorbital wrinkles). OTC clearance allows these products to be marketed and sold directly to consumers without a prescription.
Contacts: |
Kerry McAnistan |
|
Investor Relations Assistant |
||
Palomar Medical Technologies, Inc. |
||
781-993-2411 |
||
SOURCE Palomar Medical Technologies, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article